Puro Analytics
EDNA biodiversity monitoring for organisations: species detection, fish and forest surveys, lab analysis and reports
Highlights
- Young companyFounded 2025
- New on EvolcAdded 2026-10-28
About Puro Analytics
Puro Analytics provides environmental DNA (eDNA) analysis for biodiversity monitoring. Services include pathogen testing from environmental samples, forest biodiversity assessment by mapping fungi and bacteria in soil samples, fish population mapping and tracking, invasive and directive species detection, and species distribution mapping, using qPCR or NGS. It also runs tailored research projects beyond standard eDNA applications.
Customers are organisations that need biodiversity data, including for environmental impact assessments and permitting processes. Each project has three stages: survey planning and sampling (fieldwork can be done by the client or by Puro Analytics staff), laboratory analysis with bioinformatics, and a final or intermediate report with recommendations.
The company was founded in 2025 and is headquartered in Helsinki. It states that its team has carried out 40+ eDNA projects. The team includes a CEO, a COO and a Chief Scientist, supported by an advisory board and a network of scientists and industry specialists.
Product: eDNA-based species detection, population mapping and biodiversity assessment services, with laboratory analysis (qPCR or NGS) and reporting.
Jobs at Puro Analytics
More biotech & pharma companies
Rappta Therapeutics
Develops first-in-class anti-cancer molecular glues that reactivate the tumor suppressor PP2A, for oncology drug developmentNew on EvolcReagena
Diagnostic tests and laboratory reagents for clinical, biotechnology, pharmaceutical and research organizationsNew on EvolcReBio Technologies
Develops targeted, locally delivered drug conjugates for ocular cancers, starting with uveal melanomaNew on EvolcReplicon Health
Develops oral drug candidate RH013001 for aging-related degenerative diseases and seeks pharma partners to bring it to marketNew on EvolcRNatives
Develops RNA-based gene-regulating therapies for serious diseases, with research and offices in Kuopio, FinlandNew on EvolcSartar Therapeutics
Develops targeted cancer therapies for patients with gastrointestinal stromal tumours and other cancersNew on Evolc
Website technologies
Older, unverified list. Detection dates and supporting evidence are not yet available.
- Framer
- Google Tag Manager
